A new study published in the journal PLOS One as well as the National Institute of Health has found that cannabinoids can be an effective treatment for acute lung injury, or acute respiratory distress syndrome (ARDS), which is a condition caused by damage or disease to the lungs, which is often life-threatening.
The study, which was conducted by researchers at the University of São Paulo, found that: “MAGL inhibition, and consequently the increase in 2-AG levels [a naturally-occurring cannabinoid], produced anti-inflammatory effects in a murine model of LPS-induced ALI, a finding that was considered a consequence of the activation of the CB1 and CB2 receptors.”
Dr. João Palermo-Neto, one of the researchers for the study, tells us that this research has important implications in furthering the use of cannabinoids – which are found naturally in cannabis – as medicine, and as a primary (not a secondary, or supplementary) treatment for ARDS, and other lung-related conditions.
The study can be found here:
Source:
No comments:
Post a Comment